FDA Approved Medical Products for:

Cystic fibrosis

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Aztreonam
Trade Name
(Manufacturer Name)
Cayston
(Gilead Sciences)
Indication
The FDA has approved this product to be used in this manner.
To improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa
More Information about this product Drug Information Portal

Generic Name Ivacaftor
Trade Name
(Manufacturer Name)
Kalydeco
(Vertex Pharmaceuticals, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of cystic fibrosis (CF) in patients age 6 years and older who have a G551D mutation in the CFTR gene
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Dornase alfa
Trade Name
(Manufacturer Name)
Pulmozyme®
(Genentech, Inc.)
Indication
The FDA has approved this product to be used in this manner.
In conjunction with standard therapies in the management of cystic fibrosis patients to reduce the frequency of respiratory infections requiring parenteral antibiotics and to improve pulmonary function.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Tobramycin for inhalation
Trade Name
(Manufacturer Name)
Tobi®
(Novartis Pharmaceuticals Corp)
Indication
The FDA has approved this product to be used in this manner.
Management of cystic fibrosis patients with P.aeruginosa.
More Information about this product Drug Information Portal
Medline Plus Health Information